Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

BTZ Team Munich
© Tropeninstitut München

Tuberculosis: New drug substance BTZ-043 is being tested on patients for the first time

The Tropical Institute at the Hospital of the Ludwig-Maximilians-University (LMU) Munich is currently conducting a clinical study led by Professor Michael Hoelscher. Since mid-November, the first

Maria Vehreschild
© DZIF/Foto: Uwe Dettmar

Reconciling career and family life

Maria J.G.T. Vehreschild is a physician and scientist and represents the archetype “clinician-scientist” like few other. She has been Head of the Department of Infectious Diseases at Frankfurt

DZIF-Preisträger 2019
© DZIF/ Gerhard Kopatz

2019 DZIF Prizes for Translational Infection Research awarded

Gülşah Gabriel and Stefan Niemann impressed the judges with their scientific work: The German Center for Infection Research (DZIF) is awarding them both a translational infection research prize worth

multidrug-resistant E. coli bacteria
© JLU/Katrina Friese

A new antibiotic to combat drug-resistant bacteria is in sight

An international team of researchers, with the participation of Giessen University and the German Center for Infection Research (DZIF), discovered a new active substance effective against gram

Working together to develop strategies against infectious diseases

We previously thought we had conquered infectious diseases. Now they are once again one of the most common causes of death all over the world. It has since become clear that the increase in antibiotic

Masernvirus
© cdc/ Goldsmith and Bellini

Measles infections erase immunological memory – measles vaccination confers protection

Measles infections are not harmless – they can cause disease courses that may be of fatal outcome. Researchers of the Paul-Ehrlich-Institut (PEI) in co-operation with researchers from the UK and the

Florian Klein (li) und Team
© Uniklinik Köln/Dorothea Hensen

Researchers decode the immune response to Ebola vaccine

The vaccine rVSV-EBOV is currently used in the fight against Ebola virus. Since 2018, more than 200,000 people have been vaccinated. However, how the vaccine actually works was only partially known

Listeriose-pathogen
© S. Doijad, L. La Pietra

Highly virulent Listeriosis pathogen discovered

An international team of researchers identifies the genetic basis for the hypervirulence of a Listeria strain that can cause severe infections. The work was coordinated by scientists at the Justus

Pseudomonas aeruginosa
© CDC/James Archer

Could green tea hold the key to reducing antibiotic resistance?

Since the early ages green tea has been known for its numerous health benefits. A recent study goes further and shows that it also could help to fight antibiotic resistant bacteria. DZIF scientists at

The Epstein-Barr virus (EBV)
© Georg Bornkamm/Helmholtz Zentrum München

New guideline for virus infections in transplant patients

Transplant patients are particularly susceptible to viral infections as they are given medication to suppress their immune system in order to prevent rejection. Several professional associations have